American Journal of Alzheimer s Disease & Other Dementias®
ISSN 1533-3175 · SAGE Publishing · United States · active 2000–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is American Journal of Alzheimer s Disease & Other Dementias® a predatory journal?
Our screening does not flag American Journal of Alzheimer s Disease & Other Dementias®. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.
Is American Journal of Alzheimer s Disease & Other Dementias® indexed in Scopus or Web of Science?
Per our venue index, American Journal of Alzheimer s Disease & Other Dementias® appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is American Journal of Alzheimer s Disease & Other Dementias®'s impact?
Papers in American Journal of Alzheimer s Disease & Other Dementias® are cited about 2.0 times each within two years of publication, and Scimago places it in Q1, with an h-index of 91. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is American Journal of Alzheimer s Disease & Other Dementias® open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Similar venues
- Molecular NeurodegenerationQ1 · BioMed Central
- Ageing Research ReviewsQ1 · Elsevier BV
- JAMA NeurologyQ1 · American Medical Association
- Alzheimer s Research & TherapyQ1 · BioMed Central
- The Journal of Prevention of Alzheimer s DiseaseQ1 · Springer Science+Business Media
- GeroScienceQ1 · Springer International Publishing